rs200899521

Variant summary

Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PP3_Strong

The NM_014336.5(AIPL1):​c.112C>T​(p.Arg38Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000273 in 1,613,698 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.000026 ( 0 hom., cov: 30)
Exomes 𝑓: 0.000027 ( 1 hom. )

Consequence

AIPL1
NM_014336.5 missense

Scores

9
4
6

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:4

Conservation

PhyloP100: 9.60
Variant links:
Genes affected
AIPL1 (HGNC:359): (aryl hydrocarbon receptor interacting protein like 1) Leber congenital amaurosis (LCA) is the most severe inherited retinopathy with the earliest age of onset and accounts for at least 5% of all inherited retinal diseases. Affected individuals are diagnosed at birth or in the first few months of life with nystagmus, severely impaired vision or blindness and an abnormal or flat electroretinogram. The photoreceptor/pineal-expressed gene, AIPL1, encoding aryl-hydrocarbon interacting protein-like 1, is located within the LCA4 candidate region. The encoded protein contains three tetratricopeptide motifs, consistent with chaperone or nuclear transport activity. Mutations in this gene may cause approximately 20% of recessive LCA. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 4 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.946

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
AIPL1NM_014336.5 linkuse as main transcriptc.112C>T p.Arg38Cys missense_variant 2/6 ENST00000381129.8 NP_055151.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
AIPL1ENST00000381129.8 linkuse as main transcriptc.112C>T p.Arg38Cys missense_variant 2/61 NM_014336.5 ENSP00000370521 P1Q9NZN9-1

Frequencies

GnomAD3 genomes
AF:
0.0000263
AC:
4
AN:
152010
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.0000242
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000398
AC:
10
AN:
250994
Hom.:
1
AF XY:
0.0000369
AC XY:
5
AN XY:
135666
show subpopulations
Gnomad AFR exome
AF:
0.0000616
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000982
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000176
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000274
AC:
40
AN:
1461688
Hom.:
1
Cov.:
33
AF XY:
0.0000303
AC XY:
22
AN XY:
727132
show subpopulations
Gnomad4 AFR exome
AF:
0.0000597
Gnomad4 AMR exome
AF:
0.000201
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000696
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000189
Gnomad4 OTH exome
AF:
0.0000331
GnomAD4 genome
AF:
0.0000263
AC:
4
AN:
152010
Hom.:
0
Cov.:
30
AF XY:
0.0000269
AC XY:
2
AN XY:
74240
show subpopulations
Gnomad4 AFR
AF:
0.0000242
Gnomad4 AMR
AF:
0.0000655
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000294
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.00160
Hom.:
1
Bravo
AF:
0.0000416
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ExAC
AF:
0.0000330
AC:
4
EpiCase
AF:
0.0000545
EpiControl
AF:
0.0000593

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsSep 22, 2016- -
Uncertain significance, no assertion criteria providedclinical testingDepartment of Pathology and Laboratory Medicine, Sinai Health System-The AIPL1 p.Arg38Cys variant was identified in the literature in 1 of 1284 proband chromosomes (frequency: 0.0008) from individuals with Leber congenital amaurosis (Stone_2007_PMID:17964524). The variant was identified in dbSNP (ID: rs200899521) and ClinVar (classified as uncertain significance by the Center for Pediatric Genomic Medicine Children's Mercy Hospital and Clinics). The variant was identified in control databases in 11 of 282324 chromosomes (1 homozygous) at a frequency of 0.00003896 (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: Latino in 4 of 35398 chromosomes (freq: 0.000113), South Asian in 3 of 30550 chromosomes (freq: 0.000098), African in 1 of 24916 chromosomes (freq: 0.00004) and European (non-Finnish) in 3 of 128980 chromosomes (freq: 0.000023), but was not observed in the Ashkenazi Jewish, East Asian, European (Finnish), or Other populations. The p.Arg38 residue is conserved in mammals but not in more distantly related organisms, and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) suggest that the variant may impact the protein; however, this information is not predictive enough to assume pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. Data from two functional studies demonstrated that the chaperone ability of the AIPL1 protein containing the p.R38C variant did not differ significantly from the wild type (Gopalakrishna_2016_PMID:27268253), and the p.R38C variant did not significantly affect the binding of farnesyl-Cys-AMCA to AIPL1 (Majumder_2013_PMID:23737531). In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpAug 10, 2023Variant summary: AIPL1 c.112C>T (p.Arg38Cys) results in a non-conservative amino acid change located in the FKBP-type peptidyl-prolyl cis-trans isomerase domain (IPR001179) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-05 in 250994 control chromosomes in the gnomAD database, including 1 homozygote. This frequency is not significantly higher than estimated for a pathogenic variant in AIPL1 causing Leber Congenital Amaurosis (4e-05 vs 0.0011), allowing no conclusion about variant significance. c.112C>T has been reported in the literature in individuals affected with Leber Congenital Amaurosis or nonsyndromic blindness without strong evidence of causality (Stone_2007, Dineiro_2020). These reports do not provide unequivocal conclusions about association of the variant with Leber Congenital Amaurosis. Publications reports experimental evidence evaluating an impact on protein function, finding no effect of the variant on the ability for AIPL1 to interact with FAT10 or to chaperone PDE6C (Boehm_2020, Gopalakrishna_2016). The following publications have been ascertained in the context of this evaluation (PMID: 17964524, 32483926, 32817338, 27268253). Two submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Both submitters classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. -
Leber congenital amaurosis 4 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 09, 2022This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 38 of the AIPL1 protein (p.Arg38Cys). This variant is present in population databases (rs200899521, gnomAD 0.01%), including at least one homozygous and/or hemizygous individual. This missense change has been observed in individual(s) with clinical features of Leber congenital amaurosis (PMID: 17964524). ClinVar contains an entry for this variant (Variation ID: 377207). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). Experimental studies have shown that this missense change does not substantially affect AIPL1 function (PMID: 23737531, 27268253). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Pathogenic
0.27
D
BayesDel_noAF
Pathogenic
0.37
CADD
Pathogenic
33
DANN
Benign
0.97
DEOGEN2
Benign
0.39
T;.;.;.;T;T
Eigen
Pathogenic
0.77
Eigen_PC
Pathogenic
0.72
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.93
D;D;D;D;D;D
M_CAP
Uncertain
0.21
D
MetaRNN
Pathogenic
0.95
D;D;D;D;D;D
MetaSVM
Uncertain
0.68
D
MutationAssessor
Uncertain
2.2
M;M;.;M;.;.
MutationTaster
Benign
1.0
D;D;D;D;D;D;D;D
PrimateAI
Benign
0.38
T
PROVEAN
Pathogenic
-5.8
D;D;.;.;.;.
REVEL
Pathogenic
0.93
Sift
Benign
0.035
D;D;.;.;.;.
Sift4G
Pathogenic
0.0010
D;D;D;D;D;.
Polyphen
1.0
D;D;D;.;.;.
Vest4
0.83
MutPred
0.84
Gain of catalytic residue at K41 (P = 0.0519);Gain of catalytic residue at K41 (P = 0.0519);Gain of catalytic residue at K41 (P = 0.0519);Gain of catalytic residue at K41 (P = 0.0519);Gain of catalytic residue at K41 (P = 0.0519);Gain of catalytic residue at K41 (P = 0.0519);
MVP
0.97
MPC
0.87
ClinPred
0.82
D
GERP RS
4.8
Varity_R
0.58
gMVP
0.84

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs200899521; hg19: chr17-6337403; COSMIC: COSV51508582; API